SBIR/STTR Research Award

Improving Solubility, Stability and Permeability of Natural Products Extracts

Award identifier 82448e0f79d60d9d282fea97a08663151486ed40b38642fac3fb7ffc62705392Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$286,946

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SHIFA BIOMEDICAL CORPORATION
Proposal award date
2019-08-05
Contract end date
2020-07-31
UEI
J3TLJQ7LFK49
Solicitation number
PA18-607
Topic code
NCCIH

Research abstract

Project Summary Abstract Despite substantial developments of extraction and separation techniquesisolation of natural products from various sources is still a challenging taskand lead generation or validation of known natural products from plant extracts is fraught with false negativese gdue to low concentrationsinstabilityor insolubilityand false positivese gaggregatesand knownpatented or nuisance compoundsTraditional and optimized solvent based extraction methodsincluding those involving ultrasoundmicrowavesand pressure assisted extractionsupercritical fluids and solid phase extractionionic liquids and distillation have all been reported as a means to extract and separate components of different physicochemical propertiesand de replication of already known or nuisance compounds at the earliest stage of the fractionation procedure is desirableWe propose to utilize natural polymericdifferent molecular weight chitosan and methylated derivativesnanoformulationstypically employed in the lead optimization or drug development process to improve therapeutic efficacy and or reduce toxicityin the lead discovery process by employing them in the extraction process to solubilize and stabilize natural products for biological testingA proof of concept will be demonstrated with green tea extracts through the isolationquantification and assay of biological activity of the major known catechinsin particular EGCGthat react rapidly with reactive oxygen speciesROSas compared with their non nanoformulated counterpartsIn additionstudies have demonstrated a modest cholesterol lowering effect with green tea catechin extractsincluding EGCGAlthough statins have been on the market as inexpensive and safe means to control cholesterol levelsnevertheless there remains a substantial market of unmet medical need for people who are statin intolerant or statin resistantThe long term goal of this work is to demonstrate the general utility of applying nanoformulations to natural products drug discoveryin particular extraction and isolationand to developin a Phase II grantan optimized EGCG nanoformulation and test for enhanced efficacy in an animal model of cholesterol lowering in a preclinical development phaseThe specific aims of this work are toPerform nanoformulationstability and release kinetic studies with several novel natural polymer basednanoformulation methods in the green tea extraction process to improve the extraction efficiency of themajor catechinsespecially EGCGand perform stability and simulated release kinetic studies with the bestnanoformulations as compared to their non nanoformulated counterpartsRun cell based assays for measuring cholesterol absorption inhibition with the best three nanoformulatedextracts from specific aimagain comparing the biological activity to their corresponding nonnanoformulated counterpartsConfirm LDL and total cholesterol lowering in a mouse model with the best nanoformulation from specificaimwith purified EGCG in mice maintained on high fat diets to measure LDL and total cholesterollowering to demonstrate improved efficacy as compared to its non nanoformulated counterpart Project Narrative Isolation of natural products from various sources is still a challenging taskand lead generation and validation of novel or known natural products is fraught with false negatives and false positivesOur goal is to improve the efficiency of natural drug discovery during the important extraction and isolation process through application of nanoformulations to better solubilize and stabilize the chemical constituents for testing

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

16 SBIR/STTR records share this UEI (2006–2024). Reported award amounts total $12,324,333. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.